Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.

Popat RA, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, McGuire V, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM.

Eur J Neurol. 2011 May;18(5):756-65. doi: 10.1111/j.1468-1331.2011.03353.x. Epub 2011 Jan 31.

2.

Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2.

Chuang YH, Lill CM, Lee PC, Hansen J, Lassen CF, Bertram L, Greene N, Sinsheimer JS, Ritz B.

Neuroepidemiology. 2016;47(3-4):192-200. doi: 10.1159/000450855. Epub 2016 Jan 31.

3.

An attempt to replicate interaction between coffee and CYP1A2 gene in connection to Parkinson's disease.

Hill-Burns EM, Hamza TH, Zabetian CP, Factor SA, Payami H.

Eur J Neurol. 2011 Sep;18(9):e107-8; author reply e109. doi: 10.1111/j.1468-1331.2011.03464.x. No abstract available.

4.

Coffee, caffeine-related genes, and Parkinson's disease: a case-control study.

Facheris MF, Schneider NK, Lesnick TG, de Andrade M, Cunningham JM, Rocca WA, Maraganore DM.

Mov Disord. 2008 Oct 30;23(14):2033-40. doi: 10.1002/mds.22247.

5.

Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers.

Tan EK, Chua E, Fook-Chong SM, Teo YY, Yuen Y, Tan L, Zhao Y.

Pharmacogenet Genomics. 2007 Nov;17(11):1001-5.

PMID:
18075470
6.

Caffeine and Parkinson's disease: are we getting our fix on risk-modifying gene-environment interactions?

Mellick GD, Ross OA.

Eur J Neurol. 2011 May;18(5):671-2. doi: 10.1111/j.1468-1331.2011.03350.x. Epub 2011 Jan 31. No abstract available.

PMID:
21281404
7.

The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers.

Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA.

Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):912-6.

8.

Coffee, CYP1A2 genotype, and risk of myocardial infarction.

Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H.

JAMA. 2006 Mar 8;295(10):1135-41.

PMID:
16522833
9.

Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women.

Palacios N, Weisskopf M, Simon K, Gao X, Schwarzschild M, Ascherio A.

Parkinsonism Relat Disord. 2010 Jul;16(6):370-5. doi: 10.1016/j.parkreldis.2010.02.012. Epub 2010 Mar 20.

10.

Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk.

Kim IY, O'Reilly ÉJ, Hughes KC, Gao X, Schwarzschild MA, McCullough ML, Hannan MT, Betensky RA, Ascherio A.

Mov Disord. 2018 Mar;33(3):414-420. doi: 10.1002/mds.27279. Epub 2018 Jan 10.

PMID:
29318639
11.

Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum.

Singh S, Singh K, Gupta SP, Patel DK, Singh VK, Singh RK, Singh MP.

Brain Res. 2009 Aug 4;1283:115-26. doi: 10.1016/j.brainres.2009.06.002. Epub 2009 Jun 9.

PMID:
19520064
12.

Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.

Dik VK, Bueno-de-Mesquita HB, Van Oijen MG, Siersema PD, Uiterwaal CS, Van Gils CH, Van Duijnhoven FJ, Cauchi S, Yengo L, Froguel P, Overvad K, Bech BH, Tjønneland A, Olsen A, Boutron-Ruault MC, Racine A, Fagherazzi G, Kühn T, Campa D, Boeing H, Aleksandrova K, Trichopoulou A, Peppa E, Oikonomou E, Palli D, Grioni S, Vineis P, Tumino R, Panico S, Peeters PH, Weiderpass E, Engeset D, Braaten T, Dorronsoro M, Chirlaque MD, Sánchez MJ, Barricarte A, Zamora-Ros R, Argüelles M, Jirström K, Wallström P, Nilsson LM, Ljuslinder I, Travis RC, Khaw KT, Wareham N, Freisling H, Licaj I, Jenab M, Gunter MJ, Murphy N, Romaguera-Bosch D, Riboli E.

Int J Cancer. 2014 Jul 15;135(2):401-12. doi: 10.1002/ijc.28655. Epub 2013 Dec 21.

13.

High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype.

Lowcock EC, Cotterchio M, Anderson LN, Boucher BA, El-Sohemy A.

Nutr Cancer. 2013;65(3):398-409. doi: 10.1080/01635581.2013.768348.

PMID:
23530639
14.

Caffeine increases tear volume depending on polymorphisms within the adenosine A2a receptor gene and cytochrome P450 1A2.

Arita R, Yanagi Y, Honda N, Maeda S, Maeda K, Kuchiba A, Yamaguchi T, Yanagihara Y, Suzuki H, Amano S.

Ophthalmology. 2012 May;119(5):972-8. doi: 10.1016/j.ophtha.2011.11.033. Epub 2012 Feb 14.

PMID:
22336631
15.

Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption.

Josse AR, Da Costa LA, Campos H, El-Sohemy A.

Am J Clin Nutr. 2012 Sep;96(3):665-71. doi: 10.3945/ajcn.112.038794. Epub 2012 Aug 1.

PMID:
22854411
16.

Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption.

Cornelis MC, El-Sohemy A, Campos H.

Am J Clin Nutr. 2007 Jul;86(1):240-4.

PMID:
17616786
17.

Gender and ethnicity modify the association between the CYP1A2 rs762551 polymorphism and habitual coffee intake: evidence from a meta-analysis.

Denden S, Bouden B, Haj Khelil A, Ben Chibani J, Hamdaoui MH.

Genet Mol Res. 2016 Apr 4;15(2). doi: 10.4238/gmr.15027487.

18.

Association of caffeine intake and CYP1A2 genotype with ovarian cancer.

Goodman MT, Tung KH, McDuffie K, Wilkens LR, Donlon TA.

Nutr Cancer. 2003;46(1):23-9.

PMID:
12925300
19.

Exploring an interaction of adenosine A2A receptor variability with coffee and tea intake in Parkinson's disease.

Tan EK, Lu ZY, Fook-Chong SM, Tan E, Shen H, Chua E, Yih Y, Teo YY, Zhao Y.

Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):634-6.

PMID:
16823803
20.

Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients.

Palatini P, Benetti E, Mos L, Garavelli G, Mazzer A, Cozzio S, Fania C, Casiglia E.

Eur J Epidemiol. 2015 Mar;30(3):209-17. doi: 10.1007/s10654-015-9990-z. Epub 2015 Jan 17.

PMID:
25595320

Supplemental Content

Support Center